| Quarterly | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 | Jun 2016 |
|---|---|---|---|---|---|
| Total Income | 344.73 | 538.04 | 377.60 | 444.20 | 382.41 |
| Total Income Growth (%) | -35.93 | 42.49 | -14.99 | 16.16 | -12.10 |
| Total Expenses | 319.55 | 444.52 | 295.63 | 351.66 | 301.70 |
| Total Expenses Growth (%) | -28.11 | 50.36 | -15.93 | 16.56 | -13.16 |
| EBIT | 25.18 | 93.52 | 81.97 | 92.54 | 80.71 |
| EBIT Growth (%) | -73.08 | 14.09 | -11.42 | 14.66 | -7.91 |
| Profit after Tax (PAT) | 13.02 | 42.78 | 50.68 | 54.68 | 45.51 |
| PAT Growth (%) | -69.57 | -15.59 | -7.32 | 20.15 | -8.83 |
| EBIT Margin (%) | 7.30 | 17.38 | 21.71 | 20.83 | 21.11 |
| Net Profit Margin (%) | 3.78 | 7.95 | 13.42 | 12.31 | 11.90 |
| Basic EPS (₹) | 0.81 | 2.65 | 3.14 | 3.39 | 2.82 |
Dishman Pharma [Merged] - Dishman Pharmaceuticals & Chemicals [Merged] Share Price
NSE
Loading...
Dishman Pharma [Merged]...
Advertisment
Dishman Pharma [Merged] share price insights
We don’t have any Insights for this stock currently . We suggest you to explore other sections for more!
Key Metrics
PE Ratio (x) | 0.00 | ||||||||||
EPS - TTM (₹) | 0.00 | ||||||||||
MCap (₹ Cr.) | 0.00 | ||||||||||
Sectoral MCap Rank | 62 | ||||||||||
PB Ratio (x) | 0.00 | ||||||||||
Div Yield (%) | 0.64 | ||||||||||
Face Value (₹) | 2.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 0.00 | ||||||||||
52W H/L (₹) |
Dishman Pharma [Merged] Share Price Returns
| 1 Day | 1.05% |
| 1 Week | N.A. |
| 1 Month | N.A. |
| 3 Months | N.A. |
| 1 Year | N.A. |
| 3 Years | N.A. |
| 5 Years | N.A. |
Dishman Pharma [Merged] News & Analysis
Dishman Pharma [Merged] Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Dishman Pharma [Merged] Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
No reported Balance Sheet are available.
No reported Cash Flow Statement are available.
No reported Financial Ratios are available.
Dishman Pharma [Merged] Peer Comparison
Dishman Pharma [Merged] Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Dishman Pharma [Merged] Board Meeting/AGM
Dishman Pharma [Merged] Dividends
- Others
Meeting Date Announced on Purpose Details Sep 28, 2017 Aug 21, 2017 AGM Book closure from 21 Sep, 2017 to 28 Sep, 2017 Aug 10, 2017 Aug 03, 2017 Board Meeting Quarterly Results May 16, 2017 May 09, 2017 Board Meeting Audited Results Mar 17, 2017 Mar 17, 2017 Board Meeting Others Feb 13, 2017 Feb 08, 2017 Board Meeting Quarterly Results & Interim Dividend Type Dividend Dividend per Share Ex-Dividend Date Announced on Interim 60% 1.2 Feb 17, 2017 Feb 06, 2017 Interim 100% 2.0 Mar 17, 2016 Mar 08, 2016 Final 100% 2.0 Sep 10, 2015 Aug 24, 2015 Final 60% 1.2 Aug 21, 2014 May 29, 2014 Final 60% 1.2 Jul 18, 2013 May 28, 2013 All Types Ex-Date Record Date Announced on Details Bonus May 02, 2016 May 03, 2016 Feb 25, 2016 Bonus Ratio: 1 share(s) for every 1 shares held Splits Oct 21, 2005 Oct 28, 2005 Aug 31, 2005 Split: Old FV10.0| New FV:2.0
About Dishman Pharma [Merged]
Executives
Auditors
Executive details are not available.
Auditor details are not available.
Industry
Key Indices Listed on
-
Address
Bhadr - Raj Chambers,Swastik Cross Road, NavrangpuraAhmedabad, Gujarat - 380009
More Details
FAQs about Dishman Pharma [Merged] share
- 1. What is Dishman Pharma [Merged] share price and what are the returns for Dishman Pharma [Merged] share?Dishman Pharma [Merged] share price was Rs 301.20 as on 15 Oct, 2019, 09:47 AM IST. Dishman Pharma [Merged] share price was up by 1.05% based on previous share price of Rs. 186.0.
- 2. What's the market capitalization of Dishman Pharma [Merged]?Dishman Pharma [Merged] share has a market capitalization of Rs 0.00 Cr. Within Miscellaneous sector, it's market cap rank is 62.
- 3. What is 52 week high/low of Dishman Pharma [Merged] share price?52 Week high of Dishman Pharma [Merged] share is Rs 347.00 while 52 week low is Rs 127.95
- 4. What are the Dishman Pharma [Merged] quarterly results?On Consoldiated basis, Dishman Pharma [Merged] reported a total income and loss of Rs 344.73 Cr and Rs 13.02 respectively for quarter ending 2017-06-30.
Trending in Markets
Dishman Pharma [Merged] Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.
